机译:基于树突细胞的慢性淋巴细胞白血病疫苗的研制
Departments of Oncology and Hematology Karolinska University Hospital 171 76 Stockholm Sweden;
Departments of Oncology and Hematology Karolinska University Hospital 171 76 Stockholm Sweden;
Departments of Oncology and Hematology Karolinska University Hospital 171 76 Stockholm Sweden;
Departments of Oncology and Hematology Karolinska University Hospital 171 76 Stockholm Sweden;
Departments of Oncology and Hematology Karolinska University Hospital 171 76 Stockholm Sweden;
Departments of Oncology and Hematology Karolinska University Hospital 171 76 Stockholm Sweden;
Departments of Oncology and Hematology Karolinska University Hospital 171 76 Stockholm Sweden;
CLL; Dendritic cell; T cell; Immunotherapy; Clinical trial;
机译:基于树突细胞的慢性淋巴细胞白血病疫苗的研制
机译:使用CliniMACS平台大规模生产慢性淋巴细胞性白血病中基于树突细胞的疫苗。
机译:Lenalidomide作为免疫佐剂在慢性淋巴细胞白血病患者中的树突细胞疫苗
机译:使用机器学习生存率和分类方法预测慢性淋巴细胞白血病首次治疗的时间
机译:绝经后妇女慢性淋巴细胞白血病和小淋巴细胞淋巴瘤发生率的危险因素:妇女健康倡议(WHI)研究
机译:AMD3100破坏了慢性淋巴细胞白血病细胞与间质基质或护士样细胞为基础的微环境之间的串扰:其与慢性淋巴细胞白血病治疗相关的临床前证据
机译:AMD3100破坏了慢性淋巴细胞白血病细胞与间质基质或护士样细胞微环境之间的串扰:临床前证据表明其与慢性淋巴细胞白血病治疗相关。